Compare CAKE & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAKE | EVO |
|---|---|---|
| Founded | 1972 | 1993 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 1.1B |
| IPO Year | 1992 | 2021 |
| Metric | CAKE | EVO |
|---|---|---|
| Price | $51.68 | $3.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 1 |
| Target Price | ★ $57.73 | $7.00 |
| AVG Volume (30 Days) | ★ 1.1M | 269.8K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | ★ 24.69 | N/A |
| EPS | ★ 3.29 | N/A |
| Revenue | ★ $3,711,211,000.00 | $887,396,457.00 |
| Revenue This Year | $6.51 | N/A |
| Revenue Next Year | $4.67 | $8.80 |
| P/E Ratio | $15.53 | ★ N/A |
| Revenue Growth | ★ 4.90 | N/A |
| 52 Week Low | $42.69 | $2.84 |
| 52 Week High | $69.70 | $5.10 |
| Indicator | CAKE | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 61.17 | 50.69 |
| Support Level | $50.72 | $2.87 |
| Resistance Level | $52.77 | $3.05 |
| Average True Range (ATR) | 1.35 | 0.10 |
| MACD | 0.46 | 0.03 |
| Stochastic Oscillator | 82.23 | 72.97 |
The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.